Please Wait...

BioClinica and Kinapse Partner to Accelerate Risk-Based Monitoring Implementation

Bolsters Adoption of Compass Intelligent Monitoring Solution

May 21, 2015

BioClinica®, Inc., a leading specialty clinical trials services and technology provider, today announced it has partnered with Kinapse to accelerate Risk-Based Monitoring (RBM) implementation on global clinical trials using BioClinica's Compass Intelligent Monitoring solution.

"Implementing a comprehensive RBM solution can make a real difference in clinical research," BioClinica CEO John Hubbard said. "We're excited about this collaboration as it helps move the industry forward with intelligent monitoring by bringing together our technology and subject matter expertise with Kinapse's broad implementation experience."

Kinapse employs 450 professionals globally and has more than ten years of experience providing strategy and operations consultancy and capability-building programs, including RBM, to life sciences companies.

"In evaluating RBM-enabling technologies, we found BioClinica's Compass provides one of the most comprehensive solutions," said Stuart Donald, vice president of advisory services of Kinapse. "Compass is uniquely designed for RBM and has a rich tool set to solve risk and quality issues, making it the right technology in this new era of monitoring."

Kinapse's role includes easing the change management process as organizations transition to RBM. "We manage implementation from start to finish, including development of supporting processes," Donald said.

The partnership comes at a time of increasing demand for Compass and as several pilot studies using the technology show significant improvement in quality and risk reduction. BioClinica's Vice President of Clinical Innovation, Courtney McBean explained, "Compass catches issues that often go overlooked by onsite monitoring until later in the trial. Finding and fixing issues sooner is less costly and less risky than dealing with bigger problems down the road, especially when it comes to quality and safety."

BioClinica and Kinapse will make a joint presentation, Essential Steps to Successful Risk-Based Monitoring, on June 4 in Tokyo, Japan.

To learn more about BioClinica's Compass, contact Courtney McBean by emailing  Courtney.McBean[a]BioClinica.com or calling (952) 905-8810. Follow BioClinica on the Trial Blazers blog at http://www.bioclinica.com/blog, and on Twitter at http://twitter.com/bioclinica.

About Kinapse
Kinapse provides expert advisory and outsourcing services to life sciences organizations, suppliers and regulators. Kinapse clients include many of the world's leading pharmaceutical, biotechnology, medical device and specialty pharmaceutical companies, government organizations and life sciences service providers. Kinapse has a network of global locations in Europe, the U.S., and Asia Pacific. To learn more about Kinapse, visit www.kinapse.com.

About Bioclinica

Bioclinica is a global life science provider that utilizes science and technology to bring clarity to clinical trials – helping companies to develop new life-improving therapies more efficiently and safely. Successful clinical trials require the ability to see key details and uncover hidden insights, and Bioclinica's hundreds of experienced scientific, medical, and domain experts bring unmatched insight across the development lifecycle, from the initial protocol to post-approval. The company's cloud-based offerings include medical imaging and cardiac safety services; clinical adjudication; randomization and trial supply management and optimization; electronic and eSource data capture; site and patient payments and budget forecasting; pharmacovigilance; trial management; and risk-based monitoring solutions. A true multifaceted partner to trial sponsors and Contract Research Organizations (CROs), Bioclinica offers a global network of research sites and patient recruitment services to provide committed, detail-focused service through all stages of drug development. The company's thousands of employees serve more than 400 pharmaceutical, biotechnology and device organizations – including all the top 20 biopharmaceutical companies and leading CROs – through a network of offices in the U.S., Europe, and Asia.

Learn more about Bioclinica and our Clinical Adjudication and other offerings at www.Bioclinica.com and in the Bioclinica Blog. Follow the latest company news and happenings on LinkedIn and Twitter.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

RT @virtue_insight: #VIphv We are delighted to announce our new Gold Sponsor @bioclinica for our 16th Pharmacovigilance 2018 https://t.co/h…
bioclinica (5 days ago)
RT @bioclinica: Tackling the costly issue of drug supply waste in clinical trials. Find out how Novo Nordisk & other global pharmas R embra…
bioclinica (5 days ago)
Tackling the costly issue of drug supply waste in clinical trials. Find out how Novo Nordisk & other global pharmas… https://t.co/iW7Q9DfVgQ
bioclinica (2 weeks ago)
Background & key considerations to help #pharma prepare for new FDA blood pressure draft guidance issued in May. Ac… https://t.co/07dJeeD35E
bioclinica (3 weeks ago)
Tackling the costly issue of drug supply waste in clinical trials. Find out how Novo Nordisk & other global pharmas… https://t.co/tSx5tm2rgg
bioclinica (4 weeks ago)
DYK @bioclinica offers full-svc global clinical data mgmt svcs customizable to your study & program needs? Our high… https://t.co/dyXDiCtWd8
bioclinica (4 weeks ago)

Latest Blogs:

Blood pressure monitor
Prescription box
Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations